# Binding-site barrier in tumor delivery

Source: https://onco.cc/terms/binding-site-barrier/  
OnCo record `binding-site-barrier` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

An antibody can bind so readily near a tumor's blood vessels that little reaches cells farther away. Strong binding and even delivery throughout a tumor are different properties.

## Summary

Antibody uptake can be concentrated near accessible binding sites, leaving heterogeneous intratumoral distribution. A primary antibody-drug conjugate study altered antibody coadministration in a mouse xenograft model and improved penetration and efficacy without increasing the payload dose. This establishes a delivery mechanism in that model, not a dosing recommendation for patients. Distribution, retained binding and effective intracellular exposure need to be considered together.

## Fields

- Kind: Term
- Last checked: 2026-11-08
- Also known as: binding site barrier; perivascular antibody trapping

## Sources

- Tumor penetration and single-cell conjugate targeting study (2018): https://doi.org/10.1158/0008-5472.CAN-17-1638

## Connected records

- terms: [Antigen expression and treatment response](https://onco.cc/terms/antigen-expression-and-response/), [Epitope](https://onco.cc/terms/epitope/), [Evidence from measurement to patient benefit](https://onco.cc/terms/measurement-to-benefit-evidence/), [Experimental and clinical drug exposure](https://onco.cc/terms/experimental-versus-clinical-exposure/)
- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/)

---
JSON: https://onco.cc/api/v1/entities/binding-site-barrier.json